What are the contraindications for Apelix?
Apelix, as an innovative drug targeting specific types of breast cancer, is mainly used to treat hormone receptor-positive, human epidermal growth factor receptor2-negative advanced or metastatic breast cancer that carries PIK3CA gene mutations. However, when using this drug, patients need to pay special attention to some contraindications to ensure the safety and effectiveness of the treatment.
First of all, patients who have a severe allergic reaction to Apelvis or any of its components are strictly prohibited from using this drug. Allergic reactions may manifest as rash, difficulty breathing, swelling and other symptoms. Once they occur, you should stop taking the drug and seek medical advice immediately.
Secondly, pregnant women and women planning pregnancy should also avoid using Apelvis. Based on animal studies, the drug may cause harm to the fetus, such as increased embryonic mortality, decreased fetal weight, and increased rates of fetal malformations. Therefore, in order to ensure the safety of mothers and infants, this group of people should choose other appropriate treatment options.
In addition, Apelix may interact with other drugs during use. For example, strong CYP3A4 inducers may reduce the plasma concentration of apelix, thereby affecting the therapeutic effect. Therefore, patients should avoid concurrent use of these drugs while taking Apelvis. Likewise, BCRP inhibitors may also have adverse drug interactions with apelvis and their combined use should be avoided.
In addition to the above contraindications, patients should also pay close attention to their blood sugar levels while taking Apelvis. This medication may cause hyperglycemia, so regular monitoring of blood sugar and adjustments as needed are necessary.
In general, although apelvis provides a new treatment option for patients with specific types of breast cancer, there are still many drug contraindications that need to be paid attention to during use. Patients should follow medical advice and use medications rationally to ensure the safety and effectiveness of treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)